A First-in-human, Randomized and Double-blind Within Cohorts, Placebo-controlled, Single Ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP9830 Administered to Healthy Male Subjects
Latest Information Update: 15 May 2025
At a glance
Most Recent Events
- 08 May 2025 According to a Zealand Pharma media release, company anticipates completing this trial in Q4 2025 and topline data in 1H 2026.
- 20 Feb 2025 According to a Zealand Pharma media release, company anticipates completing this trial in 2025.
- 11 Nov 2024 Status changed from planning to recruiting.